An update on flexible dosing of oral therapy in metastatic colorectal cancer (mCRC)
An update on flexible dosing of oral therapy in metastatic colorectal cancer (mCRC)
Prof. Andrea Sartore-Bianchi, Dr. Guillem Argilés
Dr. Andrea Sartore-Bianchi and Dr. Guillem Argilés provide their views on flexible dosing of oral therapy in metastatic colorectal cancer (mCRC).Prof. Andrea Sartore-Bianchi
Medical Oncologist
Niguarda Cancer Center
Italy
Prof. Andrea Sartore-Bianchi has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
Dr. Guillem Argilés
Medical Oncologist
Vall d'Hebron University Hospital
Spain
Dr. Guillem Argilés has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
| 5 min | 2019
This programme was made for you: your opinion matters
Share your feedback in just 4 clicks and help us to continue to create the content you need.
I agree that this educational programme:
Was valuable to me:
1/4
Has improved my knowledge of this topic:
2/4
Is likely to change my clinical practice:
3/4
Was balanced and unbiased:
4/4
download resources
This programme was made for you: your opinion matters
Share your feedback in just 4 clicks and help us to continue to create the content you need.
I agree that this educational programme:
Was valuable to me:
1/4
Has improved my knowledge of this topic:
2/4
Is likely to change my clinical practice:
3/4
Was balanced and unbiased:
4/4
GI CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from Bayer.